Overview

Gcsf Injection in Women With Repeated Implantaiton Failure

Status:
Suspended
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see the impact of intrauterine injection of recombinant GCSF on pregnancy and implantation rate during IVF-ICSI (intracytoplasmic sperm injection) protocols as well as in frozen embryo transfer. In addition, following the injection, the level of G-CSF in the bloodstream will be verified.
Phase:
Phase 3
Details
Lead Sponsor:
Clinique Ovo
OVO R & D
Treatments:
Lenograstim